Search

Your search keyword '"Dwyer, Jamie P."' showing total 204 results

Search Constraints

Start Over You searched for: Author "Dwyer, Jamie P." Remove constraint Author: "Dwyer, Jamie P." Language english Remove constraint Language: english
204 results on '"Dwyer, Jamie P."'

Search Results

4. Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record–Based Post-Trial Follow-Up of SPRINT

5. Health Informatics Educational Offerings through ALA-Accredited LIS Programs

11. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

12. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

13. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

15. Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.

17. Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study.

18. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes.

19. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial

22. Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)

25. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study

29. Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.

30. Diabetic Proteinuria Revisited: Updated Physiologic Perspectives.

31. Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials.

41. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.

42. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.

43. Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice.

44. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.

45. Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.

46. Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials.

47. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases

48. Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

49. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).

50. Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.

Catalog

Books, media, physical & digital resources